Targeting antigens to an invariant epitope of the MHC Class II DR molecule potentiates the immune response to subunit vaccines

Virus Research

Volumn 155, Issue 1, 2011, Pages 55-60

  Gil, Félix ^a,e   Pérez Filgueira, Mariano ^a,b,f   Barderas, María G ^a,e   Pastor Vargas, Carlos ^c   Alonso, Covadonga ^a   Vivanco, Fernando ^c,d   Escribano, José M ^a  

^a INIA   (Spain)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^e HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

^f INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

Adjuvant; Antigen targeting; Canine parvovirus; RHDV; Subunit vaccine

Indexed keywords

APCH1 ANTIBODY; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOPOTENTIATION; INSECT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECIES;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL LINE; EPITOPES; HLA-DR ANTIGENS; HUMANS; LEPIDOPTERA; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; SINGLE-CHAIN ANTIBODIES; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

ANIMALIA; CANINE PARVOVIRUS; HEXAPODA; RABBIT HEMORRHAGIC DISEASE VIRUS; TRICHOPLUSIA NI;

EID: 78650573550     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.08.022     Document Type: Article

References (33)

1. Barber B.H. The immunotargeting approach to adjuvant-independent subunit vaccine design. Semin. Immunol. 1997, 9:293-301.
2. Barcena J., et al. Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus. J. Virol. 2000, 74:1114-1123.
3. Boga J.A., Martin Alonso J.M., Casais R., Parra F. A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection. J. Gen. Virol. 1997, 78(Pt 9):2315-2318.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
5. Brodersen R., et al. Analysis of the immunological cross reactivities of 213 well characterized monoclonal antibodies with specificities against various leucocyte surface antigens of human and 11 animal species. Vet. Immunol. Immunopathol. 1998, 64:1-13.
6. Bullido R., Domenech N., Alvarez B., Alonso F., Babin M., Ezquerra A., Ortuno E., Dominguez J. Characterization of five monoclonal antibodies specific for swine class II major histocompatibility antigens and crossreactivity studies with leukocytes of domestic animals. Dev. Comp. Immunol. 1997, 21:311-322.
7. Carayanniotis G., Barber B.H. Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC. Nature 1987, 327:59-61.
8. Carayanniotis G., Barber B.H. Characterization of the adjuvant-free serological response to protein antigens coupled to antibodies specific for class II MHC determinants. Vaccine 1990, 8:137-144.
9. Carayanniotis G., Vizi E., Parker J.M., Hodges R.S., Barber B.H. Delivery of synthetic peptides by anti-class II MHC monoclonal antibodies induces specific adjuvant-free IgG responses in vivo. Mol. Immunol. 1988, 25:907-911.
10. Castanon S., Marin M.S., Martin-Alonso J.M., Boga J.A., Casais R., Humara J.M., Ordas R.J., Parra F. Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus. J. Virol. 1999, 73:4452-4455.
11. Chaudhary V.K., Batra J.K., Gallo M.G., Willingham M.C., FitzGerald D.J., Pastan I. A rapid method of cloning functional variable-region antibody genes in Escherichia coli as single-chain immunotoxins. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:1066-1070.
12. Fernandez-Fernandez M.R., Mourino M., Rivera J., Rodriguez F., Plana-Duran J., Garcia J.A. Protection of rabbits against rabbit hemorrhagic disease virus by immunization with the VP60 protein expressed in plants with a potyvirus-based vector. Virology 2001, 280:283-291.
13. Fossum S., Berg S.F., Mjaaland S. Targeting antigens to antigen presenting cells. Semin. Immunol. 1992, 4:275-283.
14. Froyen G., Ronsse I., Billiau A. Bacterial expression of a single-chain antibody fragment (SCFV) that neutralizes the biological activity of human interferon-gamma. Mol. Immunol. 1993, 30:805-812.
15. Gil F., et al. High-yield expression of a viral peptide vaccine in transgenic plants. FEBS Lett. 2001, 488:13-17.
16. Gil F., Titarenko E., Terrada E., Arcalis E., Escribano J.M. Successful oral prime-immunization with VP60 from rabbit haemorrhagic disease virus produced in transgenic plants using different fusion strategies. Plant Biotechnol. J. 2006, 4:135-143.
17. Gil F., Reytor E., Perez-Filgueira D.M., Escribano J.M. Multimerization of peptide antigens for production of stable immunogens in transgenic plants. J. Biotechnol. 2007, 128:512-518.
18. Gomez-Sebastian S., Perez-Filgueira D.M., Gomez-Casado E., Nunez M.C., Sanchez-Ramos I., Tabares E., Escribano J.M. DIVA diagnostic of Aujeszky's disease using an insect-derived virus glycoprotein E. J. Virol. Methods 2008, 153:29-35.
19. Langeveld J.P., et al. First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J. Virol. 1994, 68:4506-4513.
20. Langeveld J.P., et al. Full protection in mink against mink enteritis virus with new generation canine parvovirus vaccines based on synthetic peptide or recombinant protein. Vaccine 1995, 13:1033-1037.
21. Laurent S., Vautherot J.F., Madelaine M.F., Le Gall G., Rasschaert D. Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J. Virol. 1994, 68:6794-6798.
22. Martin-Alonso J.M., Castanon S., Alonso P., Parra F., Ordas R. Oral immunization using tuber extracts from transgenic potato plants expressing rabbit hemorrhagic disease virus capsid protein. Transgenic Res. 2003, 12:127-130.
23. O'Reilly D.R., Miller L.K., Luckow V.A. Baculovirus Expression Vectors: A Laboratory Manual 1992, W.H. Freeman & Co., New York.
24. Oviedo J.M., Rodriguez F., Gomez-Puertas P., Brun A., Gomez N., Alonso C., Escribano J.M. High level expression of the major antigenic African swine fever virus proteins p54 and p30 in baculovirus and their potential use as diagnostic reagents. J. Virol. Methods 1997, 64:27-35.
25. Perez-Filgueira D.M., Gonzalez-Camacho F., Gallardo C., Resino-Talavan P., Blanco E., Gomez-Casado E., Alonso C., Escribano J.M. Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae. J. Clin. Microbiol. 2006, 44:3114-3121.
26. Perez-Filgueira D.M., Resino-Talavan P., Cubillos C., Angulo I., Barderas M.G., Barcena J., Escribano J.M. Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV. Virology 2007, 364:422-430.
27. Roche P.A., Teletski C.L., Stang E., Bakke O., Long E.O. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:8581-8585.
28. + T cell responses. Eur. J. Immunol. 2003, 33:3101-3108.
29. Skea D.L., Barber B.H. Studies of the adjuvant-independent antibody response to immunotargeting. Target structure dependence, isotype distribution, and induction of long term memory. J. Immunol. 1993, 151:3557-3568.
30. Sloots A., et al. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma. Clin. Cancer Res. 2008, 14:6933-6943.
31. Snider D.P., Segal D.M. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells. J. Immunol. 1989, 143:59-65.
32. Snider D.P., Underdown B.J., McDermott M.R. Intranasal antigen targeting to MHC class II molecules primes local IgA and serum IgG antibody responses in mice. Immunology 1997, 90:323-329.
33. Weber D.A., Buck L.B., Delohery T.M., Agostino N., Pernis B. Class II MHC molecules are spontaneously internalized in acidic endosomes by activated B cells. J. Mol. Cell Immunol. 1990, 4. 255-266; discussion 266-268.